FDA To Study How People React To Direct-to-Consumer Drug Ads

Main Category: Public Health
Also Included In: Pharma Industry / Biotech Industry;  Pharmacy / Pharmacist
Article Date: 24 Aug 2007 - 12:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

FDA on Tuesday announced plans to study whether positive images featured in direct-to-consumer television advertisements for medications "distract consumers from carefully considering and encoding" audio warnings about the treatments, the AP/Seattle Post-Intelligencer reports. For the study, FDA plans to examine the reactions of 2,000 consumers to such ads to determine whether they retain a positive impression of medications despite audio warnings about potential side effects. In addition, FDA will study the effects of text that appears on the screen during such ads.

According to FDA, text that directs consumers to company Web sites or magazine ads for more information might distract them from audio warnings about medications, while text that repeats the language of such warnings might help reinforce them. Sidney Wolfe, director of the Health Research Group at Public Citizen, said, "If advertisers were really interested in getting information about drug risks out, they'd show pictures of those problems, but you almost never see that."

In a statement, the Pharmaceutical Research and Manufacturers of America said that DTC TV ads provide consumers with important information about diseases and medications (AP/Seattle Post-Intelligencer, 8/21).

"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.